TP53 and cancer: To rule out the effect of the sequence and position of nonsense mutations on response variation to potential PTC readthrough modulators, we studied two cancer cell lines, DMS-114 and TC-71, with identical homozygous nonsense mutation R213X in their TP53 gene.